Illinois Eye and Ear InfirmaryUIC Department of Ophthalmology & Visual Sciences

Friday March 22, 2013

Retina SympoSiumMeDical & Surgical

retina upDate

2013

sIxth annual

preS

Ort

eD1St

cla

SS M

ail

u.S

. pO

Sta

ge

P A

I D

per

Mit

nO

. 149

54lO

S a

ng

eleS

, ca

agendalearn about the latest, most promising research developments and clinical advancements for emerging and established treatment therapies for macular, retinal, vascular, choroidal tumors and surgical retinal diseases.

who will benefitretina specialists, general ophthalmologists, fellows, residents, ophthalmic technicians and clinical trials coordinators.

learning objectivesUpon completion of this activity, participants should be able to:• Enumeratetheemergingtreatmentsforneovascular

and non-neovascular aMD • Explaintherationaleforanti-VEGFtreatmentsof

retinal vascular diseases• Discusstreatmentoptionsandpotentialsideeffectsoftreatments

for macular edema• Describesurgicaltreatmentsavailableforretinaldisorders• Discussthetreatmentoptionsforposteriorsegmenttumors

CME credit and accreditationthe university of illinois at chicago college of Medicine is accredited by the accreditation council for continuing Medical education to provide continuing medical education for physicians. this live activity isdesignatedforamaximumof8AMAPRACategory1Credit(s).™Physiciansshouldclaimonlythecreditcommensuratewiththeextentoftheir participation in the activity.

locationIllinois Eye and Ear Infirmaryuic Department of Ophthalomology & Visual Sciences1855WestTaylorStreet,Chicago,IL60612

CHECK OUR WEBSITE FOR A DETAILED SYMPOSIUM SCHEDULE

www.chicago.medicine.uic.edu/eye-courses

new advanceS StaRt HeRe

Reti

na

Sym

poSi

um

sIx

th

an

nu

al

1855

Wes

t Tay

lor St

reet

, Chic

ago,

IL 60

612

upco

min

g sy

mpo

sia

Mar

ch 16

-22,

2013

6th

Illin

ois E

ye R

evie

w 20

13

May

22, 2

013

2013

Spr

ing

Gla

ucom

a Sym

posiu

m

June

21, 2

013

37th

Ann

ual A

lum

ni R

esid

ent D

ay

July

31-A

ugus

t 3, 2

013

Mid

west

Ocu

lar A

ngio

grap

hy C

onfe

renc

e (M

OAC

)

Sept

embe

r 13-

14, 2

013

2013

Cor

nea S

ympo

sium

Sept

embe

r 21,

2013

Pedi

atric

Oph

thal

mol

ogy f

or th

e Non

-Oph

thal

mol

ogist

Oct

ober

2, 20

133r

d Bi

enni

al N

euro

-Oph

thal

mol

ogy S

ympo

sium

IllInoIs EyE and Ear InfIrmary faculty

COURSE DIRECTOR

Jennifer I. lim, MDProfessor of OphthalmologyMarion H. Schenk, Esq., Chair in Ophthalmology

for Research of the Aging Eye Director of Retina Service

William F. Mieler, MDProfessor of Ophthalmology, Retina ServiceVice Chair for EducationDirector, Ocular Oncology Clinic

norman P. Blair, MDProfessor of OphthalmologyDirector, Laboratory of Retinal Circulation

and Metabolism

Felix Y. Chau, MDAssistant Professor of Ophthalmology

Yannek I. leiderman, MD, PhDAssistant Professor of Ophthalmology

Mahnaz shahidi, PhDVice Chair for Research, Morton F. Goldberg

Professor of OphthalmologyProfessor of Physics in Ophthalmology Director, Applied Physics Laboratory

Michael J. shapiro, MDAssociate Clinical Professor of Ophthalmology

lawrence J. ulanski, II, MDAssistant Clinical Professor of Ophthalmology

RegiStRation welcome Jennifer I. Lim, MD

MACULAR DEgEnERATIOnnon-neovascular amd Lawrence J. Ulanski, II, MDangiogenesis Peter A. Campochiaro, MDneovascular amd: treatment algorithms Jennifer I. Lim, MDdiscussion

RETInAL VASCULAR DISEASES: DIABETIC RETInOPATHY AnD VEIn OCCLUSIOnSdiabetic macular edema Felix Y. Chau, MDnew options in treatment of pdR Jennifer I. Lim, MDSurgical management of pdR William F. Mieler, MDinvestigation diabetic Risk Factors Yannek I. Leiderman, MD, PhDevolving treatment options for Retinal venous occlusive disease Julia A. Haller, MDdiscussion

SURgERYocriplasmin targeting the vitreoretinal interface Julia A. Haller, MD

introduction of cless lecturer Jennifer I. Lim, MD

GErhard clEss EndowEd rEtIna lEcturEvitrectomy Surgery Stanley Chang, MD

adjunct in vitrectomy Kirk H. Packo, MD discussion

TUMORSnuts and Bolts of intraocular tumors Carol Shields, MD vascular tumors Carol Shields, MD discussion

IMAgIngwhite dots and Retinal imaging Lee M. Jampol, MDpediatric Retinal conditions & new Findings in Rop Michael J. Shapiro, MDRetinal oxygenation and consumption Norman P. Blair, MDimproved Surgical techniques for diabetic vitrectomy Kirk H. Packo, MDadvances and utility of Sdoct/ ao/ aF imaging Amani A. Fawzi, MDadaptive optics Mahnaz Shahidi, PhDdiscussion

Peter a. Campochiaro, MDJohns Hopkins UniversityGeorge S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience The Wilmer Institute, Johns Hopkins University School of Medicine

stanley Chang, MD Columbia University Medical CenterEdward S. Harkness Professor and ChairmanDepartment of Ophthalmology K.K. Tse and Ku Teh Ying Professor of Ophthalmology

amani a. Fawzi, MD Northwestern University Feinberg School of MedicineAssociate Professor of Ophthalmology

Julia a. haller, MDWills Eye InstituteOphthalmologist-in-Chief, The William Tasman MD Endowed Chair in OphthalmologyProfessor and ChairDepartment of Ophthalmology at Jefferson Medical College

lee M. Jampol, MDNorthwestern University Feinberg School of MedicineLouis Feinberg, MD, Professor of Ophthalmology

Kirk h. Packo, MDRush University Medical CenterProfessor and Chairman, Department of Ophthalmology

Carol shields, MDWills Eye InstituteCo-Director of the Oncology Service, Wills Eye HospitalProfessor of Ophthalmology at Thomas Jefferson University

invited SpeakeRS pRogRam friday, march 22, 2013 | 7:30am - 5:30pm

GErhard clEss EndowEd rEtIna lEcturE

stanley Chang, MDColumbia University Medical CenterK.K. Tse and Ku Teh Ying Professor of Ophthalmology

Dr. chang is among the luminaries in the retina field. He has developed and pioneered several revolutionary surgical approaches to treat complicated forms of retinal detachment, improving outcomes for patients worldwide. He developed perfluorocarbon liquids as an adjunct in vitreoretinal surgery to improve the outcomes for patients with giant retinal tears and proliferative vitreoretinopathy. His contributions to clinical trials and research on diseases oftheretinaandmaculaareprolific,resultingin110originalarticlesinpeer-reviewed journals. He has received numerous honors throughout his career including the Jackson lecture from the American Journal of Ophthalmology andtheHermanWackerPrizefromClubJulesGonin.TheAmericanAcademyofOphthalmologyhasrecognizedhisservicetotheprofessionwiththe lifetime achievement award and the Secretariat award. consistently named one of america’s best doctors, Dr. chang has had the distinction of being selected national physician of the Year by the castle connolly guides. He served as edward S. Harkness professor and chairman of the DepartmentofOphthalmologyatColumbiafrom1995through2012.

Retina SympoSium

on thE covEr: Color-enhanced scanning electron micrograph of the rods and cones in the human retina. Photo by Ralph C. Eagle, Jr. / Science Source

sIxth annual

Rohit Varma, MD, MPh Chair, Illinois Eye and Ear Infirmary, UIC Department of Ophthalmology & Visual Sciences Associate Dean for Strategic Planning , University of Illinois College of Medicine–Chicago

Onbehalfoftheorganizers,Iwouldliketoinviteyoutothe6thAnnualRetinaSymposium.Thisoutstanding meeting is directed by Dr. Jennifer lim, professor of Ophthalmology and Director of the retina Service. this course brings together the leading authorities on the diagnosis and managementofvitreoretinaldiseasesfromtheInfirmaryandtheU.S.Thecoursewillemphasizeevidence based management of common vitreoretinal conditions. a highlight of the course will beapresentationonvitrectomybyoneofthepioneersinthefield,Dr.StanleyChang.Withover150yearsofexcellenceinpatientcare,researchandeducation,theIllinoisEyeandEarInfirmary is delighted to offer this course.

FACULtY DISCLOSURE The University of Illinois, in an effort to comply with the Standards and Policies set forth by the Accreditation Council for Continuing Medical Education (ACCME) requires that all faculty members demonstrate balance, independence, objectivity, and scientific rigor in their presentations. All faculty members will disclose significant financial interests or relationships with organizations that provide products, services, or equipment being discussed during a presentation. Faculty members are also required to inform the audience of any presentation of a medical device, product, or pharmaceutical that has not been approved for such purpose by the FDA. Financial and “off-label” disclosure statements by the faculty will be made at the outset of each presentation so participants may form their own opinion about each presentation.

RegiSteR online www.signmeup.com/89080

EARLY REgISTRATIOn FEE: $75

RegistrationmustbereceivedBYMARCH15,2013.

WALK-In REgISTRATIOn FEE: $100

available as space permits.

if you cannot register online, contact lavitta steward: Phone:(312)355-3841 •Fax:(312)413-7929 •Email:vee@uic.edu DE

SIgn

: STU

DIo

DEl

UxE